The vertebrate transcription factor NF-kB is induced by over 150 dierent stimuli. Active NF-kB, in turn, participates in the control of transcription of over 150 target genes. Because a large variety of bacteria and viruses activate NF-kB and because the transcription factor regulates the expression of in¯ammatory cytokines, chemokines, immunoreceptors, and cell adhesion molecules, NF-kB has often been termed a`central mediator of the human immune response'. This article contains a complete listing of all NF-kB inducers and target genes described to date. The collected data argue that NF-kB functions more generally as a central regulator of stress responses. In addition, NF-kB activation blocks apoptosis in several cell types. Coupling stress responsiveness and anti-apoptotic pathways through the use of a common transcription factor may result in increased cell survival following stress insults.
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NF-kB, a central mediator of the human immune response
The Rel/NF-kB family of eukaryotic transcription factors is comprised of several structurally-related proteins that form homodimers and heterodimers (Chen and Ghosh, 1999, this issue) . In vertebrates, this family includes p50/p105, p52/p100, RelA (p65), cRel and RelB. These dimers bind to a set of related 10 bp DNA sites, collectively called kB sites, to regulate the expression of many genes. In most cells, Rel/NF-kB transcription complexes are present in a latent, inactive state in the cytoplasm where they are bound to an inhibitor (IkB). As described below, many stimuli can rapidly activate these transcription complexes by freeing them from their inhibitor and enabling them to translocate to the nuclues. The most common Rel/NF-kB dimer in mammals contains p50-RelA and is speci®cally called NF-kB. For the purposes of this review, NF-kB will be used to refer any induced complex that can be translocated from the cytoplasm to the nucleus and can bind to kB sites.
The transcription factor NF-kB has often been called a`central mediator of the human immune response'. How was such a reputation established and is it justi®ed? A summary of all stimuli that are known to activate NF-kB (Table 1 ) and a compilation of its many target genes (Table 2 ) may provide an answer.
In many cell types, nuclear NF-kB activity is induced by exposure to a wide variety of bacteria or bacterial products (Table 1) . Likewise, a host of viruses or their proteins activate NF-kB (Table 1) . Bacterial and viral infection certainly present situations where an adequate immune response is vital. That human cells respond to so many dierent organisms by activating the same transcription factor, NF-kB, is one reason for its reputation as a`central switch'. Moreover, homozygous disruption in mice of the genes encoding certain members of the Rel/NF-kB family, including those encoding c-Rel, p50 and RelB, leads to defects in the immune response to certain pathogens (Gerondakis et al., 1999, this issue) .
The active NF-kB transcription factor promotes the expression of over 150 target genes ( Table 2 ). The majority of proteins encoded by NF-kB target genes participate in the host immune response. These include, for example, 27 dierent cytokines and chemokines, as well as receptors required for immune recognition, such as MHC molecules, proteins involved in antigen presentation and receptors required for neutrophil adhesion and transmigration across blood vessel walls (Table 2) . These target genes alone would merit NF-kB the designation as a`central mediator of the immune response'.
Many viruses that induce NF-kB activity also harbor NF-kB binding sites in their viral promoters (Table 2) . Therefore, it seems likely that a virus would gain a selective advantage from the acquisition of a kB site in its promoter. If the transcription factor is induced either directly through viral infection or indirectly by the ensuing immune response (via in¯ammatory cytokines, for example), the kB sitecontaining viral promoter will be transactivated, resulting in enhanced viral transcription. Thus, the organism's own sword is turned against itself. The presence of a kB site in the HIV-1 promoter may have led to the activation of viral replication that was observed during trials in which IL-2 was used to stimulate T-cell replication in HIV-1-infected patients (Kovacs et al., 1995) . A low level of NF-kB activation is perhaps part of the mechanism by which some viruses, such as EBV, HSV, CMV or HIV-1, maintain their chronic infections.
A compilation of the many pathogens that induce NF-kB and a look at the function of its various target genes certainly validate the reputation this transcription factor has gained as an important regulator of the immune response. Moreover, the fact that viruses often use this protein to their advantage argues that NF-kB activity exerted an evolutionary pressure on these pathogens. (Table 2) . Similarly, there are many activators of NF-kB that are not bacterial and viral pathogens. Therefore, rather than being a central mediator of the immune response, NF-kB perhaps more generally represents a regulator of stress responses. NF-kB activity, for instance, is induced during various physiological stress conditions such as ischemia/reperfusion, liver regeneration and hemorrhagic shock (Table 1) . Physical stress in the form of irradiation as well as oxidative stress to cells also induce NF-kB (Table 1) . In this context, it appears evolutionarily bene®cial that a large variety of stress response genes, such as the inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), are in turn activated by NFkB (Table 2) . Again, NF-kB relays the information of an imminent stress and at the same time enacts a response by promoting the transcription of genes whose products alleviate the stress condition. Besides physiological stress situations, the human body is exposed to environmental hazards and therapeutic drugs, which can also exert a stress. Indeed, NF-kB is activated both by environmental stresses, such as heavy metals or cigarette smoke, and Where possible, the ®rst publication to report the data is given as a reference by therapeutic drugs, including various chemotherapeutic agents (Table 1) . One may speculate that the activators and the target genes of this multifunctional transcription factor have co-evolved. While environmental stresses and xenobiotics activate NF-kB, its target genes include many cell surface receptors, among them the mdr-1 gene, which encodes the multiple drug resistance mediator. Likewise, while modi®ed proteins such as advanced glycated end products (AGEs) induce NF-kB (Table 1) , the AGE receptor (RAGE) is an NFkB target gene (Table 2) . Another recently recognized cellular stress has been termed the ER-Overload Response (Pahl and Baeuerle, 1997a, 1997b; Pahl, 1999) . ER-overload arises from an accumulation of proteins within the endoplasmic reticulum (ER). It can occur under a variety of circumstances:
(1) a sudden increase in the production of proteins which enter the ER, for example during viral infection; (2) drugs which interfere with ER function thereby leading to protein accumulation in the organelle; (3) production of mutant proteins, which cannot fold correctly and thus accumulate in the ER; and (4) an overproduction of wild-type proteins, for example during transient transfection experiments, which overwhelm the ER folding/ processing machinery and therefore also accumulate in the organelle (Table 1) .
Agents eliciting the ER-Overload Response thus appear under various categories in Table 1 .
Cellular stress can result in the most drastic form of cellular self defense, namely programmed cell death or apoptosis. It is now clear that NF-kB can exert both pro-and anti-apoptotic eects in dierent cells types (Barkett and Gilmore, 1999, this issue) . The observation that several stimuli, among them tumor necrosis factor a (TNFa) and binding to the IgM receptor (or cross linking of the receptor with antibodies), can lead both to NF-kB activation (Table 1) and to apoptosis (Laster et al., 1988; Hasbold and Klaus, 1990) suggested that NF-kB induction was pro-apoptotic. Furthermore, both cross-linking of the Fas-receptor by anti-Fas antibodies and binding of the Trail receptors 1 and 2 stimulate NF-kB (Table 1) . Moreover, both the Fas-receptor and its ligand are encoded by NF-kB target genes (Table 2) . However, cells derived from RelA knockout mice are more susceptible to apoptosis induced by various agents, including TNFa (Beg and Baltimore, 1996; Van Antwerp et al., 1996; Wang et al., 1996a) . Likewise, binding of the Trail receptor-4 induces NF-kB but prevents Trail-mediated apoptosis (Degli-Esposti et al., 1997) , and inhibition of NF-kB restores drug-induced apoptosis sensitivity to certain drug-resistant primary leukemic cells and leukemic cell lines (Jeremias et al., 1998) . These data, together with the identi®cation of pro-survival bcl-2 homologs, B¯1/ A1, Bcl-x L and Nr13, and inhibitors of apoptosis (IAPs) as NF-kB target genes ( Table 2 ), suggest that NF-kB activation is anti-apoptotic in several cell types.
Consistent with a pro-surivival activity for NF-kB, several mitogens and growth factors stimulate NF-kB (Table 1) or are induced by NF-kB (Table 2) . Some of these mitogens, such as M-CSF and PDGF, appear to act via an autocrine loop: they activate NF-kB which in turn stimulates transcription of the growth factor Where possible, the ®rst publication to report the data is given as a reference. *Genes contain NF-kB binding sites in their promoter/enhancer regions, but further experiments are required to prove their functionality gene. Because mitogens and growth factors stimulate NF-kB activity it is logical that several early response genes are also regulated by this transcription factor (Table 2) . Thus, in addition to immune modulation and the more general stress response, NF-kB appears to promote cell survival. Teleologically speaking, it may`make sense' to couple a stress response factor to anti-apoptotic pathways. This central coordinator evokes an eective response against the stress and ensures that the cell does not succumb in the process. Many physiological mediators that bear no apparent connection to stress responses also activate NF-kB (Table 1) . Among these mediators are several, such as PAF and Bradikinin, that activate NF-kB and whose receptors are NF-kB target genes (Table 2) . Perhaps these mediators are released under conditions which have not been recognized or categorized as`stress'. This, however, is only a question of de®nition.
Of the many chemical agents that induce NF-kB activity (Table 1) , most elicit stress of some sort. Cycloheximide, for example, inhibits protein synthesis, while tunicamycin, brefeldin A, 2-deoxyglucose and monensin disrupt ER function, thereby eliciting ERoverload. Nocodazol, calchicine, podophyllotoxin and vinblastin interfere with microtubule function (Rosette and Karin, 1995) . Systematic screening of chemical libraries would surely unearth a plethora of additional agents that induce NF-kB, perhaps by interfering with vital cell functions, thereby causing stress.
In addition to the response genes already discussed, NF-kB activation leads to the transcriptional induction of various transcription factor genes, some themselves members of the Rel/NF-kB/IkB family. In this way, NF-kB limits its own activation, in that NF-kB activation results in the new synthesis of its inhibitor IkB (Table 2) . Newly-synthesized IkB can enter the nucleus and dislodge active NF-kB from its DNA binding site Baeuerle, 1990, Zabel et al., 1993) . Thus, in most cell types, NF-kB activation is transient. However, because NF-kB can induce the transcription of other transcription factors, for instance the proto-oncogene c-myc and the tumor suppressor p53, an initial NF-kB activation may indirectly induce the transcription of many more genes than the identi®ed 150 targets.
Thus, a more detailed look at inducers and targets of NF-kB suggests that this transcription factor is more than a mediator of the immune response. It appears that NF-kB is activated and induces responses to various forms of cell stress and should therefore more generally be termed a`central mediator of human stress response'. In this context it is interesting to note that certain well-studied stress situations, such as heat shock and the unfolded protein response, do not activate NF-kB. NF-kB activity, therefore, appears reserved for select but widely varied stresses.
New roles for NF-kB?
There are many NF-kB target genes whose properties and function defy classi®cation (listed under Enzymes and Miscellaneous in Table 2 ). Several of these target genes, such as vimentin, laminin, collagenase and gelatinase, appear to involve NF-kB in the regulation of cell structure and micro-environment. Such an adaptation response may also serve to reduce cell stress, however, more data are required to evaluate a role for NF-kB in these processes. Likewise, the observations that NF-kB regulates transcription of the cyclin D1 gene (Guttridge et al., 1999; Hinz et al., 1999) and may also participate in cyclin D3 gene transcription (Wang et al., 1996b) are very intriguing. If NF-kB controls cyclin transcription, this would implicate NF-kB in cell-cycle progression. However, more data are required to substantiate this idea.
Speci®city of the NF-kB response
NF-kB participates in the transcription of over 150 target genes. Are all activated when NF-kB is induced? How can this transcription factor maintain any selectivity or speci®city?
For NF-kB activation the selectivity resides mainly in the cell type targeted. Not all cell types respond equally to a given stimulus, either because they lack the cognate receptor or because they lack the required signal transduction molecules (discussed in Karin, 1999 , this issue). Thus, not every stimulus listed in Table 1 will activate NF-kB in every cell type examined.
Several dierent mechanisms confer selectivity on the transcriptional response to NF-kB activation. These include:
(1) the combinatorial response of promoter/enhancer regions, and (2) The selective activation and binding of individual Rel/NF-kB proteins.
The combinatorial response
The promoter/enhancer regions of most genes contain more than one transcription factor response element. Therefore, more than one transcription factor is usually required to induce eective transcription of a given gene. For the target genes listed in Table 2 , NFkB activity is necessary for ecient transcription. Thus, mutation of the kB site abrogates transcription of these promoters. However, NF-kB may not be sucient for full transcription, as other transcription factors are also required. This combinatorial regulation of transcription provides speci®city to a given response. While a given stimulus may activate NF-kB, if it fails to activate additional transcription factors, the target gene will not be transcribed fully.
We have demonstrated such selectivity using stably transfected cell lines, which express a chimeric p50/ VP16 protein. In this fusion protein, the p50 DNAbinding domain confers speci®c binding to kB sites, while the HSV VP16 transactivation domain provides potent transcriptional activation. Expression of the p50/VP16 protein was placed under the control of a tetracycline repressable promoter in CMS-5 ®broblast cells. While induction of p50/VP16 was sucient to activate transcription of the GM-CSF gene in these cells, transcription of the NF-kB target genes IL-1, IL-2 and IL-6 was not induced (Meerpohl and Pahl, unpublished observations). Thus, despite the almost overwhelming number of NF-kB target genes, the individual gene is selectively activated under speci®c circumstances.
Selective activation of Rel/NF-kB family members
The various members of the Rel/NF-kB family dier in their preference for speci®c DNA-binding sites (Kunsch et al., 1992) . Using random oligonucleotides and a DNA-binding assay, Kunsch et al. (1992) selected optimal DNA-binding sites for p50, RelA and c-Rel, as homodimers. The preferred binding site diers for each homodimer. Not surprisingly, such speci®city is also seen in vivo. For example, several NFkB target genes have been reported to contain binding sites that preferentially bound by RelA homodimers (e.g., ICAM-1 (Ledebur and Parks, 1995) and IL-4 (Casolaro et al., 1995) ).
Thus, the availability of dierent Rel/NF-kB heteroand homodimers, whose synthesis and activation may be controlled by distinct signal transduction pathways, provides an additional level of selectivity in NF-kBmediated gene transcription.
Demonstration of NF-kB activation and discovery of target genes
The simplest and most reliable assay to demonstrate NF-kB activation is the electrophoretic mobility shift assay (EMSA, (MuÈ ller et al., 1997) ). When combined with the appropriate controls, i.e. unstimulated control cells, as well as competition and supershift assays, the EMSA is both sensitive and accurate. Transient transfection experiments using a kB site-driven reporter gene are also frequently used. The appropriate controls include either a reporter gene lacking the kB sites, or, even better, a reporter gene preceded by mutated kB sites. Inhibition of reporter gene expression by co-transfection of an expression vector for the NF-kB inhibitor IkB provides an additional con®rmation of speci®city. All of the inducers listed in Table 1 have been demonstrated to activate NF-kB using one of these assays.
What makes a gene an NF-kB target gene? Not all genes listed in Table 2 are bona ®de NF-kB target genes. That is, genes in Table 2 preceded by an asterisk merely contain a putative NF-kB binding site in their promoter/enhancer region. To establish that a gene is truly regulated by NF-kB, the following experiments must be performed:
(1) NF-kB binding to the putative DNA site must be shown in an EMSA, preferably using cell extracts from a tissue which usually expresses the gene under investigation, and (2) the promoter/enhancer region must be cloned in front of a reporter gene and functional importance of the kB site must be demonstrated by mutagenesis.
These two experiments are required before a gene can be considered an NF-kB target. However, these data can be misleading if, for example, NF-kB can bind to a DNA sequence, but this site or adjacent sequences are occupied by other proteins in vivo. In such a scenario, NF-kB would bind the isolated site in vitro in an EMSA. Mutation of this site would result in a loss of function in reporter gene assays, but only because binding of the adjacent unidenti®ed protein is lost. Therefore, for ®nal proof of NF-kB involvement, in vivo DNA footprinting of the kB site should be performed. This, however, has not been done for the majority of the target genes listed in Table 2 . Nevertheless, the vast majority of these genes are expected to be true NF-kB target genes. Moreover, it is likely that cDNA microarray technologies and genomic sequencing will identify many other NF-kB target genes.
Summary
This article lists and categorizes the known inducers and target genes of the pleiotropic transcription factor NF-kB known to date. Compilation of these data reveals that the vast majority of NF-kB inducing agents or conditions represent a form of stress to cells. In response, many NF-kB target genes function to alleviate cell stress. In addition, NF-kB has recently been shown to inhibit apoptosis in several cell types. Therefore, NF-kB may act as a central integrator of stress responses and cell survival pathways. The rapid rate at which new NF-kB inducers and target genes are being identi®ed suggests that this transcription factor may coordinate additional cellular functions.
